Office of the National Coordinator; American Health Information Community Biosurveillance Data Steering Group Meeting, 41027 [06-6342]
Download as PDF
Federal Register / Vol. 71, No. 138 / Wednesday, July 19, 2006 / Notices
payment of dues, administrative
matters, or other policies. The proviso is
intended to preserve existing or future
rules or regulations of ACTRIS that
ABOR can demonstrate are reasonably
related to the legitimate and procompetitive purposes of the MLS.
In addition, the proposed order
requires ABOR, within thirty days after
the Order becomes final, to conform its
rules to the substantive provisions of the
Order. ABOR is also required to notify
ABOR members and participants in
ACTRIS of the Order through e-mail
communications and its Web site. The
proposed order requires notification of
changes in the structure of ABOR, and
requires ABOR to file regular written
reports of ABOR’s compliance with the
terms of the Order.
The proposed Order applies to ABOR
and entities that it owns or controls,
including ACTRIS and
Austinhomesearch.com. The Order by
its terms does not prohibit ABOR
members, or other persons or entities
independent of ABOR that receive
listing information from ABOR for use
on their Web sites, from making
independent decisions concerning their
use or display of ACTRIS listing
information that are consistent with
their contractual obligations to ACTRIS.
The proposed order will expire in 10
years.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. E6–11389 Filed 7–18–06; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the National Coordinator;
American Health Information
Community Biosurveillance Data
Steering Group Meeting
ACTION:
Announcement of meeting.
SUMMARY: This notice announces the
second meeting of the American Health
Information Community Biosurveillance
Data Steering Group in accordance with
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App.).
DATES: July 26, 2006 from 4 p.m to 6
p.m.
Mary C. Switzer Building
(330 C Street, SW., Washington, DC
20201), Conference Room 4090 (a photo
ID is needed for access to a Federal
building).
sroberts on PROD1PC70 with NOTICES
ADDRESSES:
The
meeting will be available via internet
access. Go to https://www.hhs.gov/
healthit/ahic.html for additional
information on the meeting.
SUPPLEMENTARY INFORMATION:
Dated: July 12, 2006.
Judith Sparrow,
Director, American Health Information
Community, Office of Programs and
Coordination, Office of the National
Coordinator.
[FR Doc. 06–6342 Filed 7–18–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Committee on Vital and Health
Statistics: Meeting
Pursuant to the Federal Advisory
Committee Act, the Department of
Health and Human Services (HHS)
announces the following advisory
committee meeting.
Name: National Committee on Vital and
Health Statistics (NCVHS), Subcommittee on
Standards and Security (SSS).
Time and Date: July 28, 2006, 9 a.m.–12:30
p.m.
Place: Crown Plaza Hotel, 1001 14th Street,
NW., Washington, DC 20005.
Status: Open.
Purpose: The purpose of this meeting is to
discuss issues and concerns relative to
implementation of the National Provider
Identifier (NDI), and to discuss preliminary
recommendations of the Consolidated Health
Informatics Initiative (CHI) Allergy
Workgroup.
For Further Information Contact:
Substantive program information as well as
summaries of meetings and a roster of
Committee members may be obtained from
Denise Buenning, Senior Adviser, Office of EHealth Standards and Services, Centers for
Medicare and Medicaid Services, MS: C5–
24–04, 7500 Security Boulevard, Baltimore,
MD 21244–1850, telephone: 410–786–6333
or Marjorie S. Greenberg, Executive
Secretary, NCVHS, National Center for
Health Statistics, Centers for Disease Control
and Prevention, Room 1100, Presidential
Building, 3311 Toledo Road, Hyattsville,
Maryland 20782, telephone: (301) 458–4245.
Information also is available on the NCVHS
home page of the HHS Web site: https://
www.ncvhs.hhs.gov/ where an agenda for the
meeting will be posted when available.
Should you require reasonable
accommodation, please contact the CDC
Office of Equal Employment Opportunity on
(301) 458–4EEO (4336) as soon as possible.
FOR FURTHER INFORMATION CONTACT:
Dated: July 10, 2006.
James Scanlon,
Deputy Assistant Secretary for Science and
Data Policy, Office of the Assistant Secretary
for Planning and Evaluation.
[FR Doc. 06–6341 Filed 7–18–06; 8:45 am]
https://www.hhs.gov/healthit/ahic.html.
BILLING CODE 4151–05–M
VerDate Aug<31>2005
18:28 Jul 18, 2006
Jkt 208001
PO 00000
Frm 00045
Fmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Joint Meeting of the Endocrinologic
and Metabolic Drugs Advisory
Committee and the Advisory
Committee for Pharmaceutical
Science; Notice of Meeting
AGENCY:
Sfmt 4703
Food and Drug Administration,
HHS.
ACTION:
BILLING CODE 4150–24–M
41027
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committees: Endocrinologic
and Metabolic Drugs Advisory
Committee and the Advisory Committee
for Pharmaceutical Science.
General Function of the Committees:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on October 4, 2006, from 8 a.m. to
5 p.m.
Location: Hilton, The Ballrooms, 620
Perry Pkwy, Gaithersburg, MD. The
hotel phone number is 301–977–8900.
Contact Person: Victoria FerrettiAceto, Center for Drug Evaluation and
Research (HFD–21), Food and Drug
Administration, 5600 Fishers Lane (for
express delivery, 5630 Fishers Lane, rm.
1076), Rockville, MD 20857, 301–827–
7001, e-mail:
Victoria.FerrettiAceto@fda.hhs.gov, or
FDA Advisory Committee Information
Line, 1–800–741–8138 (301–443–0572
in the Washington, DC area), codes
3014512536 or 3014512539. Please call
the Information Line for up-to-date
information on this meeting. When
available, background materials for this
meeting will be posted one business day
prior to the meeting on the FDA Web
site at https://www.fda.gov/ohrms/
dockets/ac/acmenu.htm. (Click on the
year 2006 and scroll down to
Endocrinologic and Metabolic Drugs
Advisory Committee or the Advisory
Committee for Pharmaceutical Science.)
Agenda: The joint committee will
discuss FDA’s efforts to assess the
product quality of currently marketed
levothyroxine sodium drug products.
Earlier this year, FDA requested that
manufacturers of currently marketed
levothyroxine sodium products provide
to it certain product release and stability
information. The joint committee will
consider FDA’s analyses and any
clinical significance.
Procedure: Interested persons may
present data, information, or views,
E:\FR\FM\19JYN1.SGM
19JYN1
Agencies
[Federal Register Volume 71, Number 138 (Wednesday, July 19, 2006)]
[Notices]
[Page 41027]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6342]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the National Coordinator; American Health Information
Community Biosurveillance Data Steering Group Meeting
ACTION: Announcement of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces the second meeting of the American
Health Information Community Biosurveillance Data Steering Group in
accordance with the Federal Advisory Committee Act (Pub. L. 92-463, 5
U.S.C., App.).
DATES: July 26, 2006 from 4 p.m to 6 p.m.
ADDRESSES: Mary C. Switzer Building (330 C Street, SW., Washington, DC
20201), Conference Room 4090 (a photo ID is needed for access to a
Federal building).
FOR FURTHER INFORMATION CONTACT: https://www.hhs.gov/healthit/ahic.html.
SUPPLEMENTARY INFORMATION: The meeting will be available via internet
access. Go to https://www.hhs.gov/healthit/ahic.html for additional
information on the meeting.
Dated: July 12, 2006.
Judith Sparrow,
Director, American Health Information Community, Office of Programs and
Coordination, Office of the National Coordinator.
[FR Doc. 06-6342 Filed 7-18-06; 8:45 am]
BILLING CODE 4150-24-M